Home β€Ί Stock analysis β€Ί NMTC

Neuroone Medical Technologies (NMTC) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

NMTC dips 1.9% to $1.04. Closed at $1.04, -1.89% vs the prior close of $1.06. Day range $1.01–$1.09, opened at $1.05.

Last close$1.04-1.89%
Day range1.01–1.09
Open1.05
Volume169.00K
52-week range0.96–6.12
Avg volume (20d)176.97K

NMTC daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 β€” NMTC dips 1.9% to $1.04
Oct 14, 2026 β€” NMTC slides 3.6% to $1.06
Oct 13, 2026 β€” NMTC rises 2.3% to $1.10
Oct 12, 2026 β€” NMTC slides 4.0% to $1.08
Oct 9, 2026 β€” NMTC jumps 3.7% to $1.12
Oct 8, 2026 β€” NMTC dips 2.7% to $1.08
Oct 7, 2026 β€” NMTC dips 1.8% to $1.11
Oct 6, 2026 β€” NMTC rises 1.3% to $1.13
Oct 5, 2026 β€” NMTC dips 0.4% to $1.12 on 2.6x normal volume
Oct 2, 2026 β€” NMTC jumps 13.7% to $1.12

NMTC latest news & SEC filings

Every SEC filing by or about NMTC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 5, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001213900-26-106677

Sep 8, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001971798-26-000005

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002067635-26-000002

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0002000429-26-000003

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001709738-26-000011

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001772652-26-000006

Aug 28, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001540354-26-000006

Aug 27, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-094174

Aug 13, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001213900-26-088724

Aug 13, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0001213900-26-088719

Jul 14, 2026 Β· Form SCHEDULE 13G/A β€” Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001104659-26-083525

Things to know before you trade NMTC

NMTC market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 20261.051.091.011.04169.00K
Oct 14, 20261.091.091.061.0657.50K
Oct 13, 20261.081.141.051.10108.30K
Oct 12, 20261.101.111.051.0839.70K
Oct 9, 20261.071.141.041.1280.10K
Oct 8, 20261.091.121.071.08315.30K
Oct 7, 20261.131.151.091.11115.80K
Oct 6, 20261.131.171.101.13110.00K
Oct 5, 20261.181.351.101.121.00M
Oct 2, 20260.981.200.981.12197.40K
Oct 1, 20261.031.070.960.99125.40K
Sep 30, 20261.131.141.011.0368.00K
Sep 29, 20261.291.321.051.09315.40K
Sep 28, 20261.311.341.291.3030.20K
Sep 25, 20261.331.351.281.33120.80K
Sep 24, 20261.361.391.331.33191.00K
Sep 23, 20261.401.421.341.34167.70K
Sep 22, 20261.341.401.311.38100.60K
Sep 21, 20261.411.411.301.3077.70K
Sep 18, 20261.391.401.351.39149.50K

About Neuroone Medical Technologies

Neuroone Medical Technologies (NMTC) is listed on the Nasdaq and classified by the SEC under β€œSurgical & Medical Instruments & Apparatus”. Its business address is in EDEN PRAIRIE, MN. State of incorporation: DE. Fiscal year ends September 30. SEC CIK 1500198.

NMTC board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Edward AndrleDirectorApr 7, 2026
Paul BuckmanDirectorApr 7, 2026
Jeffrey S MathiesenDirectorApr 7, 2026
Jason Richard MillsDirectorApr 7, 2026
David A RosaCEO & PresidentAug 28, 2026

Executive officers

NameTitleLatest filing
Mark ChristiansonMarket Development DirectorAug 28, 2026
Emily J. JohnsChief Administrative OfficerAug 28, 2026
Steve MertensChief Technology OfficerAug 28, 2026
David A RosaCEO & PresidentAug 28, 2026
Christopher VolkerChief Financial OfficerAug 28, 2026
David J. WambekeChief Business OfficerSep 8, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 27, 2026David J. WambekeBuy33,333$2.01
Jun 30, 2026Mark ChristiansonSale10,000$3.18
Mar 30, 2026Mark ChristiansonSale15,363$0.74
Mar 13, 2026Mark ChristiansonSale100$0.80
Mar 12, 2026Mark ChristiansonSale817$0.80
Mar 11, 2026Mark ChristiansonSale2,109$0.80
Mar 10, 2026Mark ChristiansonSale11,611$0.80
Mar 1, 2026David J. WambekeBuy1,000,000$0.67

NMTC financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Sep 30, 2025$9.10M$-3.61M-0.09$-2.84M
Sep 30, 2024$3.45M$-12.32M-0.46$-11.01M
Sep 30, 2023$1.95M$-11.86M-0.65$-12.89M
Sep 30, 2022$171.17K$-10.00M-0.63$-7.52M
Sep 30, 2021$178.15K$-9.95M-0.93$-8.60M

Latest balance sheet: total assets $6.19M, total liabilities $2.42M, cash $2.05M (as of Jun 30, 2026).

NMTC earnings / results-day log

DateFilingClose that day
Oct 5, 20268-K Item 2.02 (results)$1.12
Aug 13, 20268-K Item 2.02 (results)$1.83
May 12, 20268-K Item 2.02 (results)$4.39
Feb 17, 20268-K Item 2.02 (results)$4.07
Dec 17, 20258-K Item 2.02 (results)$4.01
Oct 6, 20258-K Item 2.02 (results)$5.98
Aug 14, 20258-K Item 2.02 (results)$4.98
May 13, 20258-K Item 2.02 (results)$3.86
Feb 12, 20258-K Item 2.02 (results)$6.72
Jan 10, 20258-K Item 2.02 (results)$6.79
Dec 17, 20248-K Item 2.02 (results)$4.75
Aug 14, 20248-K Item 2.02 (results)β€”

Related stocks Β· Surgical & Medical Instruments & Apparatus

Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Medline (MDLN)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on NMTC

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.